Clinical Laserthermia Systems: € 2.1M

We are very pleased to be granted Horizon 2020 funding. This significant amount of money, € 2,100,000 , will be spent on the validation of imILTCLS. The studies will be performed in collaboration with hospitals we have an established relationship with: in Marseille, France, Porto, Portugal and in Nottingham, the UK. The grant gives us stronger resources to bring imILTCLS to the market and to offer our method as an option in cancer treatment.

CEO Lars-Erik Eriksson